4-aminobenzoic acid has been researched along with hydroxyurea in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Foucar, CE; Stein, BL | 1 |
| Bellini, M; Burbury, K; El-Galaly, TC; Gerds, A; Gupta, V; Higgins, B; Huw, LY; Jamois, C; Katakam, S; Kovic, B; Maffioli, M; Mascarenhas, J; Mesa, R; Palmer, J; Passamonti, F; Ross, DM; Vannucchi, AM; Wonde, K; Yacoub, A | 1 |
1 review(s) available for 4-aminobenzoic acid and hydroxyurea
| Article | Year |
|---|---|
Novel therapeutic approaches in polycythemia vera.
Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Half-Life; Humans; Hydroxyurea; Interferon alpha-2; Interferon-alpha; Nitriles; para-Aminobenzoates; Polycythemia Vera; Polyethylene Glycols; Pyrazoles; Pyrimidines; Pyrrolidines; Recombinant Proteins; Salvage Therapy | 2018 |
1 trial(s) available for 4-aminobenzoic acid and hydroxyurea
| Article | Year |
|---|---|
The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study.
Topics: Humans; Hydroxyurea; Nausea; para-Aminobenzoates; Polycythemia Vera; Proto-Oncogene Proteins c-mdm2; Pyrrolidines; Splenomegaly; Vomiting | 2022 |
1 other study(ies) available for 4-aminobenzoic acid and hydroxyurea
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |